{{Rsnum
|rsid=887391
|Gene=LOC100505495
|Chromosome=19
|position=41479716
|Orientation=plus
|GMAF=0.348
|Gene_s=SLC26A6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 36.3 | 57.5
| HCB | 13.3 | 42.2 | 44.4
| JPT | 18.9 | 50.5 | 30.6
| YRI | 30.2 | 46.0 | 23.8
| ASW | 29.8 | 40.4 | 29.8
| CHB | 13.3 | 42.2 | 44.4
| CHD | 11.2 | 47.7 | 41.1
| GIH | 12.0 | 37.0 | 51.0
| LWK | 30.6 | 54.6 | 14.8
| MEX | 1.7 | 44.8 | 53.4
| MKK | 18.7 | 50.3 | 31.0
| TSI | 4.0 | 30.7 | 65.3
| HapMapRevision=28
}}
{{PMID|19318570|OA=1
}} [[rs887391]] was the most strongly associated SNP in the 19q13 region, which was a region highly associated with [[prostate cancer]] (p=9.4 x 10(-4)) based on two large studies.

{{PMID|19434657|OA=1
}} Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.

{{PMID|19549807|OA=1
}} Prostate cancer risk associated loci in African Americans.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}